Thought Leadership - 04.02.2026

Closing the Capability Gap in Biopharma Manufacturing

Closing the Capability Gap in Biopharma Manufacturing   

As biopharma manufacturing continues to expand, many organizations are feeling pressure to scale workforce quickly. In a recent byline published in Pharmaceutical Executive, Rich Tree, President of Project Farma, details why adding headcount alone will not solve the industry’s workforce challenges. Instead, he emphasizes the importance of building structured, competency-based training programs that develop true operational proficiency and support reliable, consistent performance at scale. 

The article highlights a growing gap between documented training and demonstrated capability, particularly in high-risk manufacturing environments where execution directly impacts product quality and patient safety. Drawing on lessons from other high-stakes industries, Rich outlines practical principles organizations can apply to strengthen training systems, improve workforce readiness, and support long-term operational stability as new facilities come online. 

Click here to read, Scaling Biopharma Requires Skills Competency, Not Just Headcount in PharmExec.com